8
Oct
2024

ICBio Clinical Research pvt ltd

Exhibitor at CPHI Milan 2024 stand 16F79, Finished Dosage Formulations
About Us

ICBio is a Contract Research Organization based in Bangalore, INDIA, engaged in conducting Bioequivalence / Bioavailability studies ( BA/ BE studies), Pharmacokinetic / Pharmacodynamic studies, Clinical End Point studies, and clinical safety and efficacy studies for Pharma, Biotech, Nutraeuticals, Herbals, Cosmetics and OTC Product companies by strictly adhering to 21 CFR ICH GCP regulatory compliant systems and procedures.             Our facility is approved by Drug Controller General of India (DCGI), CDSCO, ISO 9001:2015, ISO 15189:2012 / NABL Accredited Clinical Laboratory, Inspected and approved by Ministry of Health-Kazakhstan and other relevant regulatory authority requirements. We conducted the BE studies to US FDA, DCGI, FDA Philippines, MoH Khazakhstan, Tanzania, Vietnam, Ukraine and many ROW country regulatories with no observations so far.  Our BA/BE facility has state of art facilities like  Clinical pharmacology unit with ICU Beds for conducting BA/BE studies with Access controlled areas like Clinical Units / CPU, Bio analytical Laboratory, Volunteer screening, Volunteer Information centres, Central Laboratory Archives and Pharmacy....

  • IN
  • 2018
    On CPHI since
Contact info
  • 16 & 18, ICBio Towers,, Chikkabetahalli Yelahanka, 560097, Vidyaranyapura, Bengaluru, Karnataka, India
Event information
CPHI Milan 2024
  • 08 Oct 2024 - 10 Oct 2024
  • Fiera Milano, Italy
  • Visit us at stand 16F79, Finished Dosage Formulations